Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Weiden

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
The Psychiatric Clinics of North America|May 25, 2016
Redefining Medication Adherence in the Treatment of Schizophrenia: How Current Approaches to Adherence Lead to Misinformation and Threaten Therapeutic RelationshipsPeter J Weiden
The American Journal of Psychiatry|September 2, 2015
Helping Patients With Mental Illness Get Back to WorkPeter J Weiden
Postgraduate Medicine|November 30, 2006
Switching in the era of atypical antipsychotics. An updated reviewPeter J Weiden
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 16, 2013
Why are Canadians complacent about long-acting injectable antipsychotic therapies? Come on, Canada, you can do better!Peter J Weiden
The American Journal of Psychiatry|September 6, 2011
Switching antipsychotic medications: not enough, too often, or just right?Peter J Weiden
Focus (American Psychiatric Publishing)|January 25, 2020
Beyond Psychopharmacology: Emerging Psychosocial Interventions for Core Symptoms of SchizophreniaPeter J Weiden
Journal of Psychopharmacology (Oxford, England)|October 6, 2005
Switching antipsychotics: an updated review with a focus on quetiapinePeter J Weiden
The Journal of Clinical Psychiatry|February 26, 2008
Understanding and addressing adherence issues in schizophrenia: from theory to practicePeter J Weiden
Acta Psychiatrica Scandinavica|May 16, 2008
Antipsychotic-induced movement disorders - forgotten but not gonePeter J Weiden
Journal of Psychiatric Practice|January 24, 2007
EPS profiles: the atypical antipsychotics are not all the samePeter J Weiden
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
The Psychiatric Clinics of North America|May 25, 2016
Redefining Medication Adherence in the Treatment of Schizophrenia: How Current Approaches to Adherence Lead to Misinformation and Threaten Therapeutic RelationshipsPeter J Weiden
The American Journal of Psychiatry|September 2, 2015
Helping Patients With Mental Illness Get Back to WorkPeter J Weiden
Postgraduate Medicine|November 30, 2006
Switching in the era of atypical antipsychotics. An updated reviewPeter J Weiden
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 16, 2013
Why are Canadians complacent about long-acting injectable antipsychotic therapies? Come on, Canada, you can do better!Peter J Weiden
The American Journal of Psychiatry|September 6, 2011
Switching antipsychotic medications: not enough, too often, or just right?Peter J Weiden
Focus (American Psychiatric Publishing)|January 25, 2020
Beyond Psychopharmacology: Emerging Psychosocial Interventions for Core Symptoms of SchizophreniaPeter J Weiden
Journal of Psychopharmacology (Oxford, England)|October 6, 2005
Switching antipsychotics: an updated review with a focus on quetiapinePeter J Weiden
The Journal of Clinical Psychiatry|February 26, 2008
Understanding and addressing adherence issues in schizophrenia: from theory to practicePeter J Weiden
Acta Psychiatrica Scandinavica|May 16, 2008
Antipsychotic-induced movement disorders - forgotten but not gonePeter J Weiden
Journal of Psychiatric Practice|January 24, 2007
EPS profiles: the atypical antipsychotics are not all the samePeter J Weiden
Pageof 11